Keyphrases
T Cells
100%
Alpha-synuclein (α-syn)
100%
Ground Floor
100%
Preclinical Parkinson's Disease
100%
Parkinson's Disease
66%
Peripheral Blood Mononuclear Cells
44%
Patients with Parkinson's Disease
44%
Neurodegenerative Diseases
33%
Symptom Onset
33%
Adaptive Immune Response
22%
Inflammation
22%
Cytokine Response
22%
Interleukin-10
22%
T-cell Reactivity
22%
Specific T Cells
22%
Interferon-α (IFN-α)
11%
Neurodegeneration
11%
Disease Progression
11%
Innate Immune Response
11%
Pathophysiology
11%
T Cell Activation
11%
Early Intervention
11%
Early Parkinson's Disease
11%
Healthy Individuals
11%
Temporal Relations
11%
Healthy Controls
11%
Adaptive Immunity
11%
Interleukin-4 (IL-4)
11%
Regulatory Mechanism
11%
Motor Symptoms
11%
Disease-modifying Therapy
11%
Protein Aggregates
11%
Parkinson's Disease Diagnosis
11%
Distinct Population Segment
11%
Causal Relationship
11%
Disease Stage
11%
Autoreactive T Cells
11%
Pathogenic Role
11%
Single Patient
11%
Antigen-specific T Cell Response
11%
Prominent Features
11%
Multiple Lines of Evidence
11%
T Cell Epitope
11%
Intrigue
11%
High Magnitude
11%
Immune System Diseases
11%
Neuroscience
Parkinson's Disease
100%
Synuclein
100%
T Cell
100%
Peripheral Blood Mononuclear Cell
30%
Neurodegenerative Disorder
23%
Interleukin 10
15%
Acquired Immunity
15%
Neurodegeneration
7%
Epitope
7%
Interferon
7%
Interleukin 4
7%
Protein Aggregate
7%
Cell Activity
7%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Synuclein
100%
Peripheral Blood Mononuclear Cell
33%
Adaptive Immunity
25%
Interleukin 10
16%
Cytokine Response
16%
Cytokine
8%
Cell Activity
8%
Interleukin 4
8%
Immunity
8%
Interferon
8%